OTCQB: LXXGF | TSX.V: LXG

  • Company
    • Our Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
    • Join Our Team
    • News Releases
    • In the Media
    • Upcoming Events
  • Investors
    • Presentations
    • Financials
    • Share Structure
    • Stock Information
    • Investor Events
    • Investor Inquiries
  • Markets
    • Biologics Manufacturing
    • Veterinary Diagnostics
  • Products
    • MiQLab® System
    • Assay Panels
    • Request Product Information
    • I’d Like a Demonstration
  • Resources
  • Our Blog
  • Contact
    • Contact
    • Investor Inquiries
    • Support
    • Product Information
    • Subscribe for Updates
Vettimes Article: Diagnostics can help profession keep pace with pet populations

Vettimes Article: Diagnostics can help profession keep pace with pet populations

by LexaGene | Mar 10, 2022 | Veterinary Diagnostics

Future developments, such as molecular diagnostics, could prove to be game-changers, allowing veterinarians to make highly precise diagnoses through analysis of biological signals in genetic code and proteins to fine-tune the treatments needed.

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

by LexaGene | Feb 1, 2022 | Veterinary Diagnostics

Dr. Jack Regan, CEO and Founder of LexaGene gives an update to BioPub Investment group on January 26, 2021.

PCR Testing: The Gold Standard for Companion Animals

PCR Testing: The Gold Standard for Companion Animals

by Gail Winslow | Jan 20, 2022 | Veterinary Diagnostics

Learn more about the MiQLab solution offering in-clinic point-of-care veterinary diagnostic testing in ~2 hours addressing more than 50 percent of companion animal vet visits and increasing satisfaction.

There is Even a Black Friday for Buying Capital Equipment

There is Even a Black Friday for Buying Capital Equipment

by Joe Fillion | Jan 14, 2022 | Veterinary Diagnostics

LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.

Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

Combating Supply Chain Woes: Decentralize Your In-Clinic Diagnostic Testing

by Joe Fillion | Nov 18, 2021 | Veterinary Diagnostics

More than ever, vet practices are looking for efficient and cost-effective methodologies to take control of these variables and manage costs.

« Older Entries

Press Releases

  • Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology May 25, 2022
  • The Dawn of the Superbugs May 10, 2022
  • LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility April 7, 2022
  • Bacterial Culture: Is It Time to Rethink the Gold Standard? March 28, 2022
  • Antimicrobial Resistance: The Human and Animal Connection March 17, 2022

Categories

  • Biologics Manufacturing
  • Biothreat Detection
  • Human Clinical Diagnostics
  • Investor Information
  • Product Information
  • Veterinary Diagnostics
  • Contact
  • Support
  • Privacy
  • Terms
  • Site Map

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA
info@lexagene.com | 800.215.1824

Subscribe for Updates
  • Follow
  • Follow
  • Follow
  • Follow

©2022 LexaGene All Rights Reserved